Single-cell transcriptomics redefines focal neuroendocrine differentiation as a distinct prostate cancer pathology.

Quezada Urban R, Keerthikumar S, Clark A, Wang H, Phipson B, Bakshi A, Ryan A, Thorne H, Taylor RA, Lawrence MG, Risbridger GP, Toivanen R, Goode DL.

Open source

DOI
10.1002/1878-0261.70099
Published
2025-07-24
Container
Mol Oncol
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/1878-0261.70099,
  title = {Single-cell transcriptomics redefines focal neuroendocrine differentiation as a distinct prostate cancer pathology.},
  author = {Quezada Urban R and  Keerthikumar S and  Clark A and  Wang H and  Phipson B and  Bakshi A and  Ryan A and  Thorne H and  Taylor RA and  Lawrence MG and  Risbridger GP and  Toivanen R and  Goode DL.},
  year = {2025},
  journal = {Mol Oncol},
  doi = {10.1002/1878-0261.70099},
  url = {https://doi.org/10.1002/1878-0261.70099}
}

RIS

TY  - JOUR
TI  - Single-cell transcriptomics redefines focal neuroendocrine differentiation as a distinct prostate cancer pathology.
AU  - Quezada Urban R
AU  -  Keerthikumar S
AU  -  Clark A
AU  -  Wang H
AU  -  Phipson B
AU  -  Bakshi A
AU  -  Ryan A
AU  -  Thorne H
AU  -  Taylor RA
AU  -  Lawrence MG
AU  -  Risbridger GP
AU  -  Toivanen R
AU  -  Goode DL.
PY  - 2025
JO  - Mol Oncol
DO  - 10.1002/1878-0261.70099
UR  - https://doi.org/10.1002/1878-0261.70099
ER  - 

APA

R, Q. U., S, K., A, C., H, W., B, P., A, B., A, R., H, T., RA, T., MG, L., GP, R., R, T., & DL., G. (2025). Single-cell transcriptomics redefines focal neuroendocrine differentiation as a distinct prostate cancer pathology.. Mol Oncol. https://doi.org/10.1002/1878-0261.70099

Source records